NOXOPHARM LIMITED - Corporate Spotlight

Market Cap $29.22M Add to my watchlist

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel... Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

No Corporate Spotlight currently available.

(20min delay)
Last 10.5¢		Change 0.005(5.00%)		Mkt cap ! $29.22M

Open	High	Low	Value	Volume
10.0¢	10.5¢	10.0¢	$555	5.296K

Buyers (Bids)

No.	Vol.	Price($)
1	95000	10.5¢

Sellers (Offers)

Price($)	Vol.	No.
11.0¢	151971	2

View Market Depth

No.	Vol.	Price($)
5	620344	0.110
1	9523	0.105
5	149890	0.100
1	25357	0.098
2	176978	0.096

Price($)	Vol.	No.
0.120	106914	1
0.125	128094	1
0.130	166171	3
0.135	199760	1
0.140	230213	8

Last trade - 15.18pm 22/11/2024 (20 minute delay)


Last 10.5¢		Change 0.005 ( 5.00 %)
Open	High	Low	Volume
10.0¢	10.5¢	10.0¢	34078
Last updated 15.51pm 22/11/2024 ?

NOX (ASX) Chart